Recommendations for the clinical use of cardiac natriuretic peptides.
Emdin
Michele
M
Institute of Clinical Physiology, National Research Council, Pisa, Italy. emdin@ifc.cnr.it
Clerico
Aldo
A
Clemenza
Francesco
F
Galvani
Marcello
M
Latini
Roberto
R
Masson
Serge
S
Mulè
Paolo
P
Panteghini
Mauro
M
Valle
Roberto
R
Zaninotto
Martina
M
Ganau
Antonello
A
Mariotti
Rita
R
Volpe
Massimo
M
Aspromonte
Nadia
N
Cacciatore
Giuseppe
G
Cappelletti
Piero
P
L'Abbate
Antonio
A
Miglio
Federico
F
Ottani
Filippo
F
Pagani
Franca
F
Passino
Claudio
C
Plebani
Mario
M
Sarzani
Riccardo
R
Zucchelli
Giancarlo
G
D000208:Acute Disease; D009320:Atrial Natriuretic Factor / Q000378:metabolism / Q000627:therapeutic use*; D018450:Disease Progression; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D045283:Natriuretic Agents; D020097:Natriuretic Peptide, Brain / Q000378:metabolism / Q000627:therapeutic use*; D011379:Prognosis; D017461:Receptors, Atrial Natriuretic Factor
D045283:Natriuretic Agents; D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor; D017461:Receptors, Atrial Natriuretic Factor